Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics
暂无分享,去创建一个
D. Sulzer | H. Wilms | L. Zecca | F. Zucca | David Sulzer | Luigi Zecca | Henrik Wilms | Fabio A Zucca
[1] K. Jellinger,et al. Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.
[2] P. Riederer,et al. Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins , 2000, Journal of neurochemistry.
[3] T. Sokoloski,et al. Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules. , 1978, Federation proceedings.
[4] L. Pannell,et al. Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines* , 1999, The Journal of Biological Chemistry.
[5] J. Foley,et al. ON THE NATURE OF PIGMENT GRANULES IN THE CELLS OF THE LOCUS COERULEUS AND SUBSTANTIA NIGRA , 1958, Journal of neuropathology and experimental neurology.
[6] T. Hastings. Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase , 1995, Journal of neurochemistry.
[7] G. Fenichel,et al. Studies on neuromelanin: II. Melanin in the brainstems of infants and children , 1968, Neurology.
[8] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[9] S. Snyder,et al. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. , 1986, Science.
[10] B. Bergamasco,et al. Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients. , 2000, Biochimica et biophysica acta.
[11] D. Radice,et al. Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain , 1994, Journal of neurochemistry.
[12] M Gallorini,et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes , 2001, Journal of neurochemistry.
[13] S J Kish,et al. Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.
[14] N. Lindquist,et al. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin , 1988, Neuroscience Letters.
[15] F Beermann,et al. New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. , 1998, Brain research. Molecular brain research.
[16] Marsden Cd. Pigmentation in the nucleus substantiae nigrae of mammals. , 1961 .
[17] R. Fariello,et al. Neuromelanic pigment in substantia nigra neurons of rats and dogs , 1986, Neuroscience Letters.
[18] C. W. Olanow,et al. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.
[19] D. Graham. On the origin and significance of neuromelanin. , 1979, Archives of pathology & laboratory medicine.
[20] J. Langston,et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure , 1999, Annals of neurology.
[21] S. Ito,et al. Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? , 1998, Neuroscience Letters.
[22] T. Sarna,et al. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems. , 1995, Biochimica et biophysica acta.
[23] V. Tennyson,et al. Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease , 1965 .
[24] E. Rosengren,et al. Neuromelanin of the Human Substantia Nigra: A Mixed‐Type Melanin , 1994, Journal of neurochemistry.
[25] H. M. Swartz,et al. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain , 1996, Neuroscience.
[26] L. Greene,et al. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] Alberto Gatti,et al. The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease , 2002, FEBS letters.
[28] Y. Agid,et al. Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content? , 1992, Journal of neurochemistry.
[29] A H Stokes,et al. Tyrosinase mRNA is expressed in human substantia nigra. , 1997, Brain research. Molecular brain research.
[30] T. Shima,et al. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. , 1997, Free radical biology & medicine.
[31] G. Deuschl,et al. Activation of microglia by human neuromelanin is NF‐κB‐dependent and involves p38 mitogen‐activated protein kinase: implications for Parkinson's disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] M. G. Bridelli,et al. The structure of neuromelanin and its iron binding site studied by infrared spectroscopy , 1999, FEBS letters.
[33] G. C. Cotzias,et al. MELANOGENESIS AND EXTRAPYRAMIDAL DISEASES. , 1964, Federation proceedings.
[34] S. Ito,et al. Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides , 2000, Journal of neurochemistry.
[35] K. Wakamatsu,et al. The structure of neuromelanin as studied by chemical degradative methods , 2003, Journal of neurochemistry.
[36] A. Carlsson,et al. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species , 1986, Neuropharmacology.